Oncologic Outcomes After Completion Thyroidectomy for Patients with Well-Differentiated Thyroid Carcinoma

By Untch Brian   Palmer Frank   Ganly Ian   Patel Snehal   Michael Tuttle R.   Shah Jatin   Shaha Ashok  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1374-1378

Springer Publishing Company

Access to resources Recommend Favorite

Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children

By Raval Mehul  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2545-2553

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of whole-body retention of iodine-131 (131I) after postoperative remnant ablation for differentiated thyroid carcinoma – thyroxine withdrawal versus rhTSH administration: A retrospective comparison

By      

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 617-620

Spandidos Publications

Access to resources Recommend Favorite

A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy

By Bal C. S.   Kumar Ajay   Chandra Prem   Dwivedi S. N.   Pant G. S.  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1067-1072

Informa Healthcare

Access to resources Recommend Favorite

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodinerefractory differentiated thyroid carcinoma

By        

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 480-486

Spandidos Publications

Access to resources Recommend Favorite